Results 91 to 100 of about 815 (103)

Simple Green Spectrophotometric & Chromatographic Assay of the Oral Antiviral Treatment of COVID -19: Molnupiravir -EIDD-2801

Egyptian Journal of Chemistry, 2022
mona Abdel Moneim, Miranda Kamal, Mohamed Hamdy   +2 more
openaire   +1 more source

Electronic, intermolecular, quantum computational investigations, molecular docking and simulation studies of the potent antiviral drug EIDD-2801

Journal of the Indian Chemical Society, 2023
R. Niranjana Devi, P. Pounraj, S Birendra Kumar, A. Saral, J. Kileyoba Vinnarasi, C. Vivek, P. Parasuraman, Ahmad Irfan, S. Muthu   +8 more
openaire   +1 more source

Preparing anti-SARS-CoV-2 agent EIDD-2801 by a practical and scalable approach, and quick evaluation machine learning

Acta Pharmaceutica Sinica B, 2021
Zhiyu Li, Xi Feng, Jinlei Bian
exaly  

The prophylactic and therapeutic efficacy of the broadly active antiviral ribonucleoside -Hydroxycytidine (EIDD-1931) in a mouse model of lethal Ebola virus infection

Antiviral Research, 2023
Jason E Comer, Trevor Brasel, Shuli Mao
exaly  

Impact of Disease States on the Oral Pharmacokinetics of EIDD-1931 (an Active Form of Molnupiravir) in Rats for Implication in the Dose Adjustment

Molecular Pharmaceutics, 2023
Debaraj Mukherjee, Utpal Nandi, Diksha Manhas   +2 more
exaly  

A Concise Route to MK-4482 (EIDD-2801) from Cytidine: Part 2

Synlett, 2021
Frank Gupton, Timothy F. Jamison, David R Snead   +2 more
exaly  

Dehydration-Driven Nanomechanical Responses of the Antiviral Drug EIDD-1931

Crystal Growth and Design, 2023
Surojit Bhunia, Chilla Malla Reddy, Mangalampalli S R N Kiran   +2 more
exaly  

Conversion of N-acyl amidines to amidoximes: a convenient synthetic approach to molnupiravir (EIDD-2801) from ribose†

RSC Advances, 2021
Debaraj Mukherjee, Qazi Naveed Ahmed, Ajaz Ahmed   +2 more
exaly  

Neurotherapeutic Potential of Water-Soluble pH-Responsive Prodrugs of EIDD-036 in Traumatic Brain Injury

Journal of Medicinal Chemistry, 2023
Savita K Sharma, Bushra Wali, Luke Hodson   +2 more
exaly  

Therapeutically administered ribonucleoside analogue MK-4482/EIDD-2801 blocks SARS-CoV-2 transmission in ferrets

Nature Microbiology, 2020
Robert M Cox, Richard K Plemper, Josef D Wolf   +2 more
exaly